Freedom Investment Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,549
Closed -$151K 460
2025
Q2
$151K Buy
+10,549
New +$145K 0.01% 711
2023
Q1
Sell
-12,225
Closed -$182K 755
2022
Q4
$182K Buy
+12,225
New +$199K 0.02% 670
2022
Q2
Sell
-9,414
Closed -$221K 797
2022
Q1
$221K Buy
9,414
+157
+2% +$3.84K 0.02% 704
2021
Q4
$252K Buy
+9,257
New +$248K 0.02% 737
2021
Q3
Sell
-6,663
Closed -$201K 879
2021
Q2
$201K Buy
+6,663
New +$197K 0.02% 826
2018
Q4
Sell
-9,411
Closed -$453K 850
2018
Q3
$453K Buy
+9,411
New +$432K 0.03% 562
2018
Q2
Sell
-7,110
Closed -$396K 1052
2018
Q1
$396K Buy
+7,110
New +$390K 0.02% 759
2017
Q1
Sell
-3,913
Closed -$261K 1090
2016
Q4
$261K Sell
3,913
-559
-13% -$36.4K 0.02% 753
2016
Q3
$296K Buy
+4,472
New +$306K 0.02% 647

Other funds holding MD

Freedom Investment Management's MD Position: Q3 2025 in Review

Freedom Investment Management sold out of Pediatrix Medical (MD) in Q3 2025, closing a stake of 10,549 shares — an estimated $151K sold.

Freedom Investment Management first reported a position in MD in Q3 2016 and held it in 9 quarters. The position peaked at $453K in Q3 2018. 268 funds tracked by Wall St. Rank hold MD as of Q3 2025.

  • Freedom Investment Management reported no remaining Pediatrix Medical position as of Q3 2025 after selling out during the quarter.
  • Freedom Investment Management sold 10,549 Pediatrix Medical shares in Q3 2025, an estimated $151K.
  • Freedom Investment Management first reported a position in Pediatrix Medical in Q3 2016 and held it in 9 quarters.
  • Freedom Investment Management's Pediatrix Medical position peaked at $453K in Q3 2018.
  • 268 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2025.

Based on Freedom Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.